HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial | Synapse
June 13, 2023Open Access
HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial
Key Points
Key points are not available for this paper at this time.
Abstract
The trial is registered at ClinicalTrials.gov; NCT05364411 (registered on May 6th, 2022).